These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12599340)

  • 21. Orrin hatch and the dietary supplement health and education act: Pandora's Box revisited.
    Pray WS
    J Child Neurol; 2012 May; 27(5):561-3. PubMed ID: 22535888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sebotropic eruption associated with use of oral kava kava supplement.
    Huynh JC; Asgari MM; Moore MM
    Clin Exp Dermatol; 2014 Oct; 39(7):816-8. PubMed ID: 25214405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misconceptions and misleading information prevail--less regulation does not mean less danger to consumers: dangerous herbal weight loss products.
    Sardina J
    J Law Health; 1999-2000; 14(1):107-32. PubMed ID: 11187364
    [No Abstract]   [Full Text] [Related]  

  • 25. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary supplements in the US: pitfalls and safety.
    Walker R; Hilsden RJ
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):60-1. PubMed ID: 16456554
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin and supplement do's and don'ts.
    Consum Rep; 2013 Oct; 78(10):8-9. PubMed ID: 24032178
    [No Abstract]   [Full Text] [Related]  

  • 28. Why the United States still needs improved dietary supplement regulation and oversight.
    Morrow JD
    Clin Pharmacol Ther; 2008 Mar; 83(3):391-3. PubMed ID: 18285784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary supplements of botanicals and other substances: a new era of regulation.
    McNamara SH
    Food Drug Law J; 1995; 50(3):341-8. PubMed ID: 10343003
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural hazards. Tonic or toxic? Americans are gobbling up nature's remedies for everything from obesity to depression.
    Spake A
    US News World Rep; 2001 Feb; 130(6):42-9. PubMed ID: 11216231
    [No Abstract]   [Full Text] [Related]  

  • 32. Dietary supplements: what is in the public's best interest?
    Talbott SM
    Science; 1999 Dec; 286(5448):2269-70; author reply 2270-1. PubMed ID: 10636786
    [No Abstract]   [Full Text] [Related]  

  • 33. Concerns over kava have the FDA's attention.
    Mayo Clin Health Lett; 2002 Jul; 20(7):4. PubMed ID: 12132472
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA's response to food, dietary supplement, and cosmetic adverse events.
    Bren L
    FDA Consum; 2003; 37(4):12-3. PubMed ID: 12971342
    [No Abstract]   [Full Text] [Related]  

  • 35. The Food and Drug Administration's actions on ephedra and androstenedione: understanding their potential impacts on the protections of the Dietary Supplement Health and Education Act.
    Siegner AW
    Food Drug Law J; 2004; 59(4):617-28. PubMed ID: 15880877
    [No Abstract]   [Full Text] [Related]  

  • 36. When food is poison: the history, consequences, and limitations of the Food Allergen Labeling and Consumer Protection Act of 2004.
    Derr LE
    Food Drug Law J; 2006; 61(1):65-165. PubMed ID: 16838459
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    JAMA; 2003 Jan; 289(1):36-7. PubMed ID: 12515265
    [No Abstract]   [Full Text] [Related]  

  • 39. An innovative model for regulating supplement products: natural health products in Canada.
    Nestmann ER; Harwood M; Martyres S
    Toxicology; 2006 Apr; 221(1):50-8. PubMed ID: 16472903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A brief report of student research: mechanism of analgesic effect and efficacy and anesthesia interactions of kava in the male Sprague-Dawley rat.
    Sullivan J; Romm J; Reilly M
    Dimens Crit Care Nurs; 2009; 28(3):138-40. PubMed ID: 19387280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.